Sana Biotechnology

Sana Biotechnology Employees

5 people indexed:

Nate Hardy

Chief Financial Officer

w62f.l59xk@qvku.74f Sign up to see email

5q47.7k5bl@3z54.iq9 Sign up to see email
Patrick Yang

Director

09e7xb5.0hbv@3608.d4x Sign up to see email

6lj81q9.dlfh@dv7z.374 Sign up to see email
Richard Mulligan

Vice Chairman

x4bvkxb.kkve76y7@k9zt.6ff Sign up to see email

ttfw7k2.qt184btj@bt12.btv Sign up to see email
Robert Nelsen

Director

3jh2w0.pyux67@29y9.hv3 Sign up to see email

w1zzp5.huhh81@yv39.q97 Sign up to see email
Steve Harr

President and Chief Executive Officer

93d1z.wwbd@8lqd.iq2 Sign up to see email

0uxqi.z263@jpyi.6b3 Sign up to see email

Sana Biotechnology Company Information

Sana Biotechnology is dedicated to creating and delivering engineered cells as medicines for patients. The company operates out of Seattle, Cambridge, and South San Francisco. Sana is advancing a number of innovative drug candidates targeting diseases such as cancer, diabetes, and autoimmune disorders. They are developing platforms capable of repairing and controlling genes in cells or replacing any cell in the body. Sana engages in research and development with leading academic laboratories and industry partners. Their pipeline includes advanced programs like allogeneic CAR T programs targeting CD19+ cancers and autoimmune diseases, as well as a stem cell-derived pancreatic islet cell program for type 1 diabetes.

Report inaccurate information